Literature DB >> 27196595

Lymphotoxin β receptor signalling executes Helicobacter pylori-driven gastric inflammation in a T4SS-dependent manner.

Raquel Mejías-Luque1,2, Jessica Zöller3, Florian Anderl1, Elena Loew-Gil1, Michael Vieth4, Thure Adler5, Daniela B Engler6, Sabine Urban6, Jeffrey L Browning7, Anne Müller6, Markus Gerhard1,2, Mathias Heikenwalder3,8.   

Abstract

OBJECTIVE: Lymphotoxin β receptor (LTβR) signalling has been implicated in inflammation-associated tumour development in different tissues. We have analysed the role of LTβR and alternative NF-κB signalling in Helicobacter pylori-mediated gastric inflammation and pathology.
DESIGN: We analysed several ligands and receptors of the alternative NF-κB pathway, RelB, p52 nuclear translocation and target genes in tissue samples of H. pylori-infected patients with different degrees of gastritis or early gastric tumours by in situ hybridisation, immunohistochemistry, Western blot and real-time PCR analyses. Molecular mechanisms involved in LTβR activation by H. pylori were assessed in vitro using human gastric cancer cell lines and distinct H. pylori isolates. The effects of blocking or agonistically activating LTβR on gastric pathology during challenge with a human pathogenic H. pylori strain were studied in a mouse model.
RESULTS: Among the tested candidates, LT was significantly increased and activated alternative NF-κB signalling was observed in the gastric mucosa of H. pylori-infected patients. H. pyloriinduced LTβR-ligand expression in a type IV secretion system-dependent but CagA-independent manner, resulting in activation of the alternative NF-κB pathway, which was further enhanced by blocking canonical NF-κB during infection. Blocking LTβR signalling in vivo suppressed H. pylori-driven gastritis, whereas LTβR activation in gastric epithelial cells of infected mice induced a broadened pro-inflammatory chemokine milieu, resulting in exacerbated pathology.
CONCLUSIONS: LTβR-triggered activation of alternative NF-κB signalling in gastric epithelial cells executes H. pylori-induced chronic gastritis, representing a novel target to restrict gastric inflammation and pathology elicited by H. pylori, while exclusively targeting canonical NF-κB may aggravate pathology by enhancing the alternative pathway. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  EPITHELIAL CELLS; HELICOBACTER PYLORI - GASTRITIS; HELICOBACTER PYLORI - PATHOGENESIS

Mesh:

Substances:

Year:  2016        PMID: 27196595     DOI: 10.1136/gutjnl-2015-310783

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  Mitochondria supply sub-lethal signals for cytokine secretion and DNA-damage in H. pylori infection.

Authors:  Benedikt Dörflinger; Mohamed Tarek Badr; Aladin Haimovici; Lena Fischer; Juliane Vier; Arlena Metz; Bianca Eisele; Peter Bronsert; Konrad Aumann; Jens Höppner; Collins Waguia Kontchou; Ishita Parui; Arnim Weber; Susanne Kirschnek; Georg Häcker
Journal:  Cell Death Differ       Date:  2022-05-03       Impact factor: 15.828

Review 2.  Gastric organoids: Advancing the study of H. pylori pathogenesis and inflammation.

Authors:  Sulaimon Idowu; Paul P Bertrand; Anna K Walduck
Journal:  Helicobacter       Date:  2022-04-05       Impact factor: 5.182

3.  Polarised epithelial monolayers of the gastric mucosa reveal insights into mucosal homeostasis and defence against infection.

Authors:  Francesco Boccellato; Sarah Woelffling; Aki Imai-Matsushima; Gabriela Sanchez; Christian Goosmann; Monika Schmid; Hilmar Berger; Pau Morey; Christian Denecke; Juergen Ordemann; Thomas F Meyer
Journal:  Gut       Date:  2018-02-21       Impact factor: 23.059

4.  LncRNA HOXA-AS3 promotes gastric cancer progression by regulating miR-29a-3p/LTβR and activating NF-κB signaling.

Authors:  Feng Qu; Bin Zhu; Yi-Lin Hu; Qin-Sheng Mao; Ying Feng
Journal:  Cancer Cell Int       Date:  2021-02-18       Impact factor: 5.722

Review 5.  Manifold role of ubiquitin in Helicobacter pylori infection and gastric cancer.

Authors:  Olga Sokolova; Michael Naumann
Journal:  Cell Mol Life Sci       Date:  2021-04-07       Impact factor: 9.261

6.  Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.

Authors:  Chenxi He; Fanting Kong; Xinying Zhu; Fanlei Kong; Wei Zhao; Yanling Liu; Kuixiang Wang
Journal:  Biomed Res Int       Date:  2021-11-30       Impact factor: 3.411

7.  Bioinformatics Analysis Revealing the Correlation between NF-κB Signaling Pathway and Immune Infiltration in Gastric Cancer.

Authors:  Qiuxiang Chen; Xiaojing Du; Pengcheng Ruan; Yumei Ye; Jin Zheng; Sunkuan Hu
Journal:  Comput Math Methods Med       Date:  2022-07-28       Impact factor: 2.809

8.  Functional antagonism between CagA and DLC1 in gastric cancer.

Authors:  Isabel Hinsenkamp; Jan P Köhler; Christoph Flächsenhaar; Ivana Hitkova; Sabine Eberhart Meessen; Timo Gaiser; Thomas Wieland; Christel Weiss; Christoph Röcken; Michael Mowat; Michael Quante; Karin Taxauer; Raquel Mejias-Luque; Markus Gerhard; Roger Vogelmann; Nadja Meindl-Beinker; Matthias Ebert; Elke Burgermeister
Journal:  Cell Death Discov       Date:  2022-08-13

9.  TIFA has dual functions in Helicobacter pylori-induced classical and alternative NF-κB pathways.

Authors:  Gunter Maubach; Michelle C C Lim; Olga Sokolova; Steffen Backert; Thomas F Meyer; Michael Naumann
Journal:  EMBO Rep       Date:  2021-07-30       Impact factor: 8.807

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.